[1] | Biala G., Fidecka S., Langwinski R.: The central action of six derivatives of 1,2-benzisoxazolinone-3 in the preliminary evaluation. Annales UMCS, Sectio DDD Pharmacia, Lublin, IV, 8, 53-62, 1991 |
[2] | Thiébot M.H., Guyon A., Assouly-Besse F., Biala G., Puech A.: Neuroleptics and the ability of animals to experience pleasure. Clinical Neuropharmacology 15, 552A-553A, 1992 |
[3] | Guyon A., Assouly-Besse F., Biala G., Puech A.J., Thiébot M.H.: Potentiation by low doses of selected neuroleptics of food-induced conditioned place preference in rats. Psychopharmacology 110, 460-466, 1993 |
[4] | Biala G.: Przydatnosc testu uwarunkowanej preferencji miejsca w badaniach farmakologicznych. Doctoral thesis, 1994, Lublin, ss 75 |
[5] | Biala G., Langwinski R.: Drug reinforcement studied by the use of place conditioning in rats. Annales UMCS, Sectio DDD Pharmacia, Lublin, VIII, 1-10, 1995 |
[6] | Biala G., Langwinski R.: Rewarding properties of some drugs studied by place preference conditioning. Polish Journal of Pharmacology 48, 425-430, 1996 |
[7] | Biala G., Langwinski R.: Effects of calcium channel antagonists on the reinforcing properties of morphine, ethanol and cocaine as measured by place conditioning. Journal of Physiology and Pharmacology 47, 497-502, 1996 |
[8] | Biala G.: Antidepressant-like properties of some serotonin receptor ligands and calcium channel antagonists measured with the forced swimming test in mice. Polish Journal of Pharmacology 50, 117-124, 1998 |
[9] | Biala G., Kotlinska J.: Blockade of the acquisition of ethanol-induced conditioned place preference by N-methyl-D-aspartate receptor antagonists. Alcohol and Alcoholism 34, 175-182, 1999 |
[10] | Biala G.: Effects of calcium channel ligands on anaesthetic properties of ethanol in mice. Polish Journal of Pharmacology 51, 125-130, 1999 |
[11] | Kotlinska J., Biala G.: Effects of the NMDA/glycine receptor antagonist, L-701,324, on morphine-and cocaine-induced place preference. Polish Journal of Pharmacology 51, 323-330, 1999 |
[12] | Biala G.: Effects of pre-treatment of some calcium channel antagonists on amphetamine-induced hyperactivity and conditioned place preference. Annales UMCS, Sectio DDD Pharmacia, Lublin, XII/XIII, 3, 23-31, 1999/2000 |
[13] | Kotlinska J., Biala G.: Memantine and ACPC affect conditioned place preference induced by cocaine in rats. Polish Journal of Pharmacology 52, 179-185, 2000 |
[14] | Biala G.: Haloperidol-induced catalepsy is influenced by calcium channel antagonists. Acta Poloniae Pharmaceutica- Drug Research, 57, 233-237, 2000 |
[15] | Spielewoy C., Biala G., Roubert C., Hamon M., Betancur C., Giros B.: Hypolocomotor effects of acute and daily D-amphetamine in mice lacking the dopamine transporter. Psychopharmacology 159, 2-9, 2001 |
[16] | Duarte C., Biala G., Le Bihan C., Hamon M., Thiébot M.H.: Respective roles of dopamine D2 and D3 receptors in food-seeking behaviour in rats. Psychopharmacology 166, 19-32, 2003 |
[17] | Biala G.: Calcium channel antagonists suppress nicotine-induced place preference and locomotor sensitization in rodents. Polish Journal of Pharmacology 55, 327-335, 2003 |
[18] | Kotlinska J., Rafalski P., Biala G., Dylag T., Rolka K., Silberring J.: Nociceptin inhibits acquisition of amphetamine-induced place preference and sensitization to stereotypy in rats. European Journal of Pharmacology 474, 233-239, 2003 |
[19] | Biala G., Weglinska B.: Calcium channel antagonists attenuate cross-sensitization to the rewarding and/or locomotor effects of nicotine, morphine and MK-801. Journal of Pharmacy and Pharmacology 56, 1021-1028, 2004 |
[20] | Biala G., Weglinska B.: Calcium channel antagonists attenuate cross-sensitization to the locomotor effects of nicotine and ethanol in mice. Polish Journal of Pharmacology 56, 391-397, 2004 |
[21] | Kotlinska J., Biala G., Rafalski P., Bochenski M., Danysz W.: Effect of neramexane on ethanol dependence and reinforcement. European Journal of Pharmacology 503, 95-98, 2004 |
[22] | Weglinska B., Biala G.: Rewarding effects of nicotine in animal models. Annales UMCS, Sectio DDD Pharmacia, Lublin, XVII, 13, 105-111, 2004 |
[23] | Biala G.: Behavioral and pharmacological characteristics of mice lacking the dopamine transporter. Postepy Higieny i Medycyny Doswiadczalnej 58, 560-564, 2004 |
[24] | Biala G., Betancur C., Mansuy I.M., Giros B.: The reinforcing effects of chronic d-amphetamine and morphine are impaired in a line of memory-deficient mice overexpressing calcineurin. European Journal of Neuroscience 21, 3089-3096, 2005 |
[25] | Biala G., Weglinska B.: Blockade of the expression of mecamylamine-precipitated nicotine withdrawal by calcium channel antagonists. Pharmacological Research 51, 483-488, 2005 |
[26] | Biala G., Budzynska B., Kruk M.: Naloxone precipitates nicotine abstinence syndrome and attenuates nicotine-induced antinociception in mice. Pharmacological Reports 57, 755-760, 2005 |
[27] | Weglinska B., Biala G.: Pharmacology of calcium channel antagonists- properties and therapeutic perspectives. Annales UMCS, Sectio DDD Pharmacia, Lublin, XVIII, 11, 71-78, 2005 |
[28] | Biala G.: Pharmacological and molecular aspects of drug dependence (Farmakologiczne i molekularne aspekty uzaleznien lekowych). Habilitation thesis, Lublin 2005. ISBN 83-920919-8-1 |
[29] | Biala G., Budzynska B.: Reinstatement of nicotine-conditioned place preference by drug priming: Effects of calcium channel antagonists. European Journal of Pharmacology 537, 85-93, 2006 |
[30] | Biala G., Weglinska B.: On the mechanism of cross-tolerance between morphine-and nicotine-induced antinociception: involvement of calcium channels. Progress in Neuro-Psychopharmacology and Biological Psychiatry 30, 15-21, 2006 |
[31] | Biala G., Budzynska B.: Effects of acute and chronic nicotine on elevated plus maze in mice: Involvement of calcium channels. Life Sciences 79, 81-88, 2006 |
[32] | Kruk M., Biala G.: Animal models of anxiety. Annales UMCS, Sectio D Medicina, Lublin, LXI, N1, 335-341, 2006 |
[33] | Bernat P., Talarek S., Listos J., Biala G.: The outlook on benzodiazepines: pharmacology, clinical use and their dependence liability. Annales UMCS, Sectio DDD Pharmacia, Lublin, XIX, N1, 15-22, 2006 |
[34] | Kruk M., Biala G.: Open mazes- specific animal models of memory and learning. Annales UMCS, Sectio DDD Pharmacia, Lublin, XIX, N 2, 95-105, 2006 |
[35] | Budzynska B., Biala G.: Reinstatement of drug addiction in animal models. Annales UMCS, Sectio DDD Pharmacia, Lublin, XIX, N 2, 89-95, 2006 |
[36] | Biala G.: Memory processes and addiction: Involvement of the calcineurin signaling pathway. Postepy Higieny i Medycyny Doswiadczalnej 61, 199-203, 2007 |
[37] | Biala G., Kruk M.: Amphetamine-induced anxiety-related behavior in animal models. Pharmacological Reports 59, 636-644, 2007 |
[38] | Biala G., Kruk M.: Calcium channel antagonists suppress cross-tolerance to the anxiogenic effects of D-amphetamine and nicotine in the mouse elevated plus maze. Progress in Neuro-Psychopharmacology and Biological Psychiatry 32, 54-61, 2008 |
[39] | Biala G., Budzynska B.: Calcium-dependent mechanisms of the reinstatement of nicotine-conditioned place preference by drug priming in rats. Pharmacology, Biochemistry and Behavior 89, 116-125, 2008 |
[40] | Biala G.: Cannabinoid dependence in animal models. Postepy Higieny i Medycyny Doswiadczalnej 62, 258-262, 2008 |
[41] | Biala G., Kruk M.: Cannabinoid receptor ligands suppress memory-related effects of nicotine in the elevated plus maze in mice. Behavioural Brain Research 192, 198-202, 2008 |
[42] | Staniak N., Biala G.: Pharmacotherapy of nicotine addiction. Annales UMCS, Sectio DDD Pharmacia, Lublin, XXI, N 2, 17, 103-109, 2008 |
[43] | Biala G.: The role of cannabinoid system in the behavioral effects of nicotine. Annales UMCS, Sectio DDD Pharmacia, Lublin, XXI, N 2, 16, 99-102, 2008 |
[44] | Biala G., Kruk M.: Effects of co-administration of bupropion and nicotine or D-amphetamine on the elevated plus maze test in mice. Journal of Pharmacy and Pharmacology 61, 493-502, 2009 |
[45] | Budzynska B., Kruk M., Biala G.: Effects of the cannabinoid CB1 receptor antagonist AM 251 on the reinstatement of nicotine-conditioned place preference by drug priming in rats. Pharmacological Reports 61, 304-310, 2009 |
[46] | Biala G., Kruk M.: Influence of bupropion and calcium channel antagonists on the nicotine-induced memory-related response of mice in the elevated plus maze. Pharmacological Reports 61, 236-244, 2009 |
[47] | Biala G., Budzynska B., Staniak N.: Effects of rimonabant on the reinstatement of nicotine-conditioned place preference by drug priming in rats. Behavioural Brain Research 202, 260-265, 2009 |
[48] | Biala G., Kruk M., Budzynska B.: Effects of the cannabinoid receptor ligands on anxiety-related effects of d-amphetamine and nicotine in the mouse elevated plus maze test. Journal of Physiology and Pharmacology 60, 2, 113-122, 2009 |
[49] | Biala G.: Interactions between nicotine and morphine in animal paradigms. Annales UMCS, Sectio DDD Pharmacia, vol.22 (N2), 75-79, 2009 (PK=6). |
[50] | Biala G., Staniak N., Budzynska B.: Effects of varenicline and mecamylamine on the acquisition, expression, and reinstatement of nicotine-conditioned place preference by drug priming in rats. Naunyn-Schmiedeberg's Archives of Pharmacology 381(4), 361-370, 2010 |
[51] | Biala G., Staniak N.: Varenicline and mecamylamine attenuate locomotor sensitization and cross-sensitization induced by nicotine and morphine in mice. Pharmacology, Biochemistry and Behavior 96, 141-147, 2010 |
[52] | Biala G., Budzynska B.: Rimonabant attenuates sensitization, cross-sensitization and cross-reinstatement of place preference induced by nicotine and ethanol. Pharmacological Reports 62, 797-807, 2010 |
[53] | Tendera K., Kruk M., Biala G.: Alzheimer's disease: causes, symptoms and pharmacotherapy. Annales UMCS, Sectio DDD, vol. XXIII, No 3, 107-114, 2010 |
[54] | Budzynska B., Biala G.: Effects of bupropion on the reinstatement of nicotine-induced conditioned place preference by drug priming in rats. Pharmacological Reports 63, 362-371, 2 |
[55] | Polak P., Biala G. Psychostimulant drugs- pharmacology and pharmacotherapy of addiction. Annales UMCS, Sectio DDD Pharmacia, XXIV, 1, 155-161 |
[56] | Budzynska B., Biala G. WIN55,212-2, CB1 receptor agonist, does not cause physical dependence in Swiss mice. Annales UMCS, Sectio DDD Pharmacia, XXIV, 1, 95-102 |
[57] | Bacq A, Balasse L, Biala G., Gulard B., Gardier AM, Schinkel A., Lois F., Vialou V., Martres MP., Chevarin C., Hamon M., Giros B., Gautron S. Organic cation transporter 2 controls brain norepinephrine and serotonin clearance and antidepressant response. Molecular Psychiatry 2011; doi: 10.1038/mp.2011.87 |